Non-Random Chromosomal Rearrangements and Their Implications in Clinical Features and Outcome of Multiple Myeloma and Plasma Cell Leukemia

References

• Rabbitts T. H. Chromosomal translocations in human cancer. Nature 1994; 372: 143–149
   PubMed Web of Science ®Google Scholar
• Philip P., Drivsholm A. G-banding analysis of complex aneuploidy in multiple myeloma bone marrow cells. Blood 1976; 47: 69–77
   PubMed Web of Science ®Google Scholar
• Ligang W., Hopper J. E., Rowley J. D. Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer 1979; 44: 630–644
   PubMed Web of Science ®Google Scholar
• Philip P., Drivsholm A., Hansen N. E., Jensen M. K., Killman S. A. Chromosomes and survival in multiple myeloma. A banding study of 25 cases. Cancer Genet Cytogenet 1980; 2: 243–257
   Web of Science ®Google Scholar
• Ueshima Y., Fukuhara S., Nagai K., Takatsuki K., Uchino H. Cytogenetic studies and clinical aspects of patients with plasma cell leukeima and leukemic macroglobulinemia. Cancer Res 1983; 43: 905–912
   PubMed Web of Science ®Google Scholar
• Van den Berghe, Vermaelen K., Louwagie A., Criel A., Mecucci C., Vaerman J. P. High incidence of chromosome abnormalities in IgG3 myeloma. Cancer Genet. Cytogenet 1984; 11: 381–387
   PubMed Web of Science ®Google Scholar
• Ferti A., Panani A., Arapakis S., Raptis S. Cytogenetic study in multiple myeloma. Cancer Genet. Cytogenet 1984; 12: 247–253
   PubMed Web of Science ®Google Scholar
• Lewis J. P., Mackenzie M. R. Non-random chromosomal aberrations associated with multiple myeloma. Hematol. Oncol 1984; 2: 307–317
   PubMedGoogle Scholar
• Dewald G. W., Kyle R. A., Hicks G. A., Greipp P. R. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985; 66: 380–390
   PubMed Web of Science ®Google Scholar
• Chen K. C., Bevan P. C., Matthews J. G. Analysis of G banded karyotypes in myeloma cell. J. clin. Pathol 1986; 39: 260–266
   PubMed Web of Science ®Google Scholar
• Ranni N. S., Slavutsky I., Wechsler A., Brieux S. Chromosome finding in multiple myeloma. Cancer Genet. Cytogenet 1987; 25: 309–316
   PubMed Web of Science ®Google Scholar
• Gould J., Alexanian R., Goodacre A., Pathak S., Hecht B., Barlogie B. Plasma cell karyotype in multiple myeloma. Blood 1988; 71: 453–456
   PubMed Web of Science ®Google Scholar
• Nishida K., Taniwaki M., Misawa S., Abe T. Nonrandom rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell phenotype. Cancer Res 1989; 49: 1275–1281
   PubMed Web of Science ®Google Scholar
• Taniwaki M., Nishida K., Takashima T., Nakagawa H., Fujii H., Tamaki T., Shimazaki C., Horiike S., Misawa S., Abe T., Kashirna K. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 1994; 84: 2283–2290
   PubMed Web of Science ®Google Scholar
• Van den Berghe H. Chromosomes in plasma-cell malignancies. Eur. J. Haematol. Suppl 1989; 51: 47–51
   PubMedGoogle Scholar
• Weh H. J., Selbach J., Fiedler W., Hossfeld D. K. An identical translocation t(1;20)(q12.3;p13) in two patients with multiple myeloma. Brit. J. Haematol 1990; 74: 365–367
   PubMed Web of Science ®Google Scholar
• Nishida K., Yashige H., Maekawa T., Fujii H., Taniwaki M., Shigeo H., Misawa S., Inazawa J., Abe T. Chromosome rearrangement, t(6;14)(p21.1;q23.3), in multiple myeloma. Brit. J. Haematol 1989; 71: 295–296
   PubMed Web of Science ®Google Scholar
• Barlogie B., Alexanian R., Dixon D., Smith L., Smallwood L., Delasalle K. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood 1985; 66: 338–341
   PubMed Web of Science ®Google Scholar
• Clark R. E., Geddes A. D., Whittaker J. A., Jacobs A. Differences in bone marrow cytogenetic characteristics between treated and untreated myeloma. Eur. J. Cancer Clin. Oncol 1989; 25: 1789–1793
   PubMedGoogle Scholar
• Smith L., Barlogie B., Alexanian R. Biclonal and hypodiploid multiple myeloma. Am. J. Med 1986; 80: 841–843
   PubMed Web of Science ®Google Scholar
• Abe T., Tsuda S., Maekawa T., Taniwaki M., Sonoda Y., Ide T., Misawa S., Takino T., Inoue K. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: Consideration of the harzard of drugs as possible mutagens and carcinogens causing second malignancies. Cancer Treat Report 1985; 69: 505–514
   PubMedGoogle Scholar
• Latreille J., Barlogie B., Gohde W., Johnston D., Drewinko B., Alexanian R. Cellular DNA content as a marker of human multiple myeloma. Blood 1980; 55: 403–408
   PubMed Web of Science ®Google Scholar
• Bunn P. A., Krasnow S., Makuch R. W., Schlam M., Schechter G. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma. Blood 1982; 59: 528–535
   PubMed Web of Science ®Google Scholar
• Le Beau M. M., Albain K. S., Larson R. A., Vardiman J. W., Davis E. M., Blough R. R., Golomb H. M., Rowley J. D. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and nonlymphocytic leukemia: Further evidence for characteristic abnormalities No. 5 and 7. J. Clin. Oncol 1986; 4: 325–345
   PubMed Web of Science ®Google Scholar
• Carroll A. J., Crist W. M., Parmley R. T., Roper M., Cooper M. D., Finley W. M. Pre-B cell leukemia associated with chromosome translocation 1;19. Blood 1984; 63: 721–724
   PubMed Web of Science ®Google Scholar
• Mellentin J. D., Murre C., Donlon T. A., McCaw P. S., Smith S. D., Carroll A. J., McDonald M. E., Baltimore D., Cleary M. L. The gene for enhancer binding protein E12?E47 lies at the t(1;19) breakpoint in acute leukemias. Science 1989; 246: 379–382
   PubMed Web of Science ®Google Scholar
• Kaname T., Miyauchi T., Kuwano A., Matsuda Y., Muramatsu T., Kajii T. Mapping basigin (BSG), a member of the immunoglobulin superfamily, to 19p13.3. Cytogenet. Cell Genet 1993; 64: 195–197
   PubMedGoogle Scholar
• Yamada K., Shionoya S., Amano M., Imamura Y. A Burkitt-type 8;14 translocation in a case of plasma cell leukemia. Cancer Genet. Cytogenet 1983; 9: 67–70
   PubMed Web of Science ®Google Scholar
• Nishida K., Taniwaki M., Misawa S., Abe T., Takino T., Fujii H. Translocation t(14;18) found in a patient with multiple myeloma. Cancer Genet. Cytogenet 1987; 25: 375–377
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Trent J. M., van den Berghe H. Report of the committee on structural chromosome changes in neoplasia. Cytogenet. Cell. Genet 1987; 46: 344–366
   PubMedGoogle Scholar
• Rowley J. D. Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17. Proc. Natl. Acad. Sci. USA 1977; 74: 5729–5733
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle V., Atkin N. B. Break points in chromosome #1 abnormalities of 218 human neoplasms. Cancer Genet. Cytogenet 1981; 4: 215–225
   PubMed Web of Science ®Google Scholar
• Fukuhara S., Kita K., Nasu K., Kannagi M., Kamezaki T., Ohono H., Yamazawa M., Nishigori M., Uchino H., Yagita M., Matsuo N., Yamabe H., Tanaka S. Karyotype evolution in B-cell lymphoid malignancy with an 8;14 translocation. Int. J. Cancer 1983; 32: 555–562
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Secondary chromosome aberrations in the acute leukemias. Cancer Genet. Cytogenet 1986; 22: 331–338
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Louwagle A., Broeckaert-Van Orshoven A., David G., Verwllghen R., Michaux J. L., Sokal G. Philadelphia chromosome in human multiple myeloma. J. Natl. Cancer Inst 1979; 63: 11–16
   PubMed Web of Science ®Google Scholar
• Karpas A., Fisher P., Swirsky D. Human myeloma cell line carrying a Philadelphia chromosome. Science 1982; 216: 997–999
   PubMed Web of Science ®Google Scholar
• Taniwaki M., Matsuda F., Jauch A., Nishida K., Takashima T., Tagawa S., Sugiyama H., Misawa S., Abe T., Kashima K. Detection of 14q32 translocation in B-cell malignancies by in situ hybridization with yeast artificial chromosome clones containing the human IgH gene locus. Blood 1994; 83: 2962–2969
   PubMed Web of Science ®Google Scholar
• Taniwaki M., Nishida K., Ueda Y., Misawa S., Nagai M., Tagawa S., Yamagami T., Sugiyama H., Abe M., Fukuhara S., Kashima K. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell maliganancies by double-color fluorescence in situ hybridization. Blood 1995; 85: 3223–3228
   PubMed Web of Science ®Google Scholar
• Barlogie B., Epstein J., Selvanayagan P., Alexanian R. Plasma cell myeloma-new biological insights and advances in therapy. Blood 1989; 73: 865–879
   PubMed Web of Science ®Google Scholar